Joan Lo to Prospective Studies
This is a "connection" page, showing publications Joan Lo has written about Prospective Studies.
Connection Strength
0.725
-
Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
Score: 0.119
-
Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):32-41.
Score: 0.042
-
Change in physical activity during active treatment in a prospective study of breast cancer survivors. Breast Cancer Res Treat. 2012 Jan; 131(2):679-90.
Score: 0.039
-
Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg. 2010 Nov; 145(11):1055-63.
Score: 0.036
-
A practical method for collecting food record data in a prospective cohort study of breast cancer survivors. Am J Epidemiol. 2010 Dec 01; 172(11):1315-23.
Score: 0.036
-
Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
Score: 0.034
-
Identifying Key Risk Factors for Dizziness Handicap in Middle-Aged and Older People. J Am Med Dir Assoc. 2020 03; 21(3):344-350.e2.
Score: 0.034
-
The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer. Cancer Causes Control. 2019 Feb; 30(2):187-193.
Score: 0.032
-
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
Score: 0.029
-
NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007 Aug; 18(6):613-20.
Score: 0.028
-
Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study. Breast Cancer Res Treat. 2016 08; 159(1):119-29.
Score: 0.027
-
Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus: A Prospective Cohort Study. Ann Intern Med. 2015 Dec 15; 163(12):889-98.
Score: 0.026
-
Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
Score: 0.025
-
Retinopathy and progression of CKD: The CRIC study. Clin J Am Soc Nephrol. 2014 Jul; 9(7):1217-24.
Score: 0.023
-
Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. J Ren Nutr. 2014 May; 24(3):186-93.
Score: 0.023
-
Physical performance and frailty in chronic kidney disease. Am J Nephrol. 2013; 38(4):307-15.
Score: 0.022
-
Patient-physician interaction and quality of life in recently diagnosed breast cancer patients. Breast Cancer Res Treat. 2013 Jun; 139(2):581-95.
Score: 0.022
-
Influence of breastfeeding during the postpartum oral glucose tolerance test on plasma glucose and insulin. Obstet Gynecol. 2012 Jul; 120(1):136-43.
Score: 0.020
-
Study of Women, Infant Feeding, and Type 2 diabetes mellitus after GDM pregnancy (SWIFT), a prospective cohort study: methodology and design. BMC Public Health. 2011 Dec 23; 11:952.
Score: 0.020
-
Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
Score: 0.020
-
Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: the SWIFT cohort. Diabetes Care. 2012 Jan; 35(1):50-6.
Score: 0.019
-
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011 Jun 15; 305(23):2432-9.
Score: 0.019
-
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009; 11(3):R31.
Score: 0.016
-
The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
Score: 0.015